The positron emission tomography combined with computer tomography (PET/CT) is a well
established imaging modality in the oncological practice. The most frequently used …

Over the last years, PET has developed rapidly, with the most relevant indications being in
oncologic imaging. Particularly since the introduction of PET-CT it is suggested that PET will …

Positron emission tomography (PET) provides high-resolution images of
radiopharmaceutical biodistribution in vivo. Fluorine-18–labeled fluorodeoxyglucose (FDG) …

Cardiac neoplasms are divided into primary and secondary. Secondary neoplasms are 20 to
40 times more common than the primary ones. Although rare, primary cardiac neoplasms …

Nuclear medicine involves the administration of radiopharmaceuticals to patients with
ultimate aim of mapping their localization with state-of-the-art single photon emission …

Recently, positron emission tomography (PET) has been increasingly used also in clinical
cardiac imaging. The newest development, the hybrid imaging devices with 64-slice …

Positron emission tomography (PET) is a non-invasive imaging technique that employs
positron-emitting radionuclides labelled to biological molecules. Unlike other imaging …

The capability of positron emission tomography (PET) to generate images that are triggered
to the electrocardiogram (ECG) is a powerful extension to its already documented expertise …

Primary cardiac tumors are rare. Myxoma and sarcoma are the most common types of
benign and malignant cardiac tumors, respectively. Secondary cardiac tumors, the majority …

Clinical positron emission tomography (PET) is a molecular imaging method that has
recently emerged from being a research tool to a mainstream imaging modality. PET uses a …